215 related articles for article (PubMed ID: 23049865)
1. PTEN/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1.
Goo CK; Lim HY; Ho QS; Too HP; Clement MV; Wong KP
PLoS One; 2012; 7(9):e45806. PubMed ID: 23049865
[TBL] [Abstract][Full Text] [Related]
2. alpha(1A) adrenergic receptor induces eukaryotic initiation factor 4E-binding protein 1 phosphorylation via a Ca(2+)-dependent pathway independent of phosphatidylinositol 3-kinase/Akt.
Rybkin II; Cross ME; McReynolds EM; Lin RZ; Ballou LM
J Biol Chem; 2000 Feb; 275(8):5460-5. PubMed ID: 10681523
[TBL] [Abstract][Full Text] [Related]
3. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors.
She QB; Halilovic E; Ye Q; Zhen W; Shirasawa S; Sasazuki T; Solit DB; Rosen N
Cancer Cell; 2010 Jul; 18(1):39-51. PubMed ID: 20609351
[TBL] [Abstract][Full Text] [Related]
4. The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Ding M; Van der Kwast TH; Vellanki RN; Foltz WD; McKee TD; Sonenberg N; Pandolfi PP; Koritzinsky M; Wouters BG
Mol Cancer Res; 2018 Apr; 16(4):682-695. PubMed ID: 29453322
[TBL] [Abstract][Full Text] [Related]
5. Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma.
Jacobson BA; De A; Kratzke MG; Patel MR; Jay-Dixon J; Whitson BA; Sadiq AA; Bitterman PB; Polunovsky VA; Kratzke RA
Br J Cancer; 2009 Aug; 101(3):424-31. PubMed ID: 19603014
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
O'Reilly KE; Warycha M; Davies MA; Rodrik V; Zhou XK; Yee H; Polsky D; Pavlick AC; Rosen N; Bhardwaj N; Mills G; Osman I
Clin Cancer Res; 2009 Apr; 15(8):2872-8. PubMed ID: 19336517
[TBL] [Abstract][Full Text] [Related]
7. Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.
Murai A; Asa SA; Kodama A; Hirata A; Yanai T; Sakai H
BMC Vet Res; 2012 Jul; 8():128. PubMed ID: 22839755
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1.
Azar R; Najib S; Lahlou H; Susini C; Pyronnet S
Cell Mol Life Sci; 2008 Oct; 65(19):3110-7. PubMed ID: 18810319
[TBL] [Abstract][Full Text] [Related]
9. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
[TBL] [Abstract][Full Text] [Related]
11. ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1.
Rolli-Derkinderen M; Machavoine F; Baraban JM; Grolleau A; Beretta L; Dy M
J Biol Chem; 2003 May; 278(21):18859-67. PubMed ID: 12618431
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway.
He Z; Gao Y; Deng Y; Li W; Chen Y; Xing S; Zhao X; Ding J; Wang X
PLoS One; 2012; 7(4):e35926. PubMed ID: 22563417
[TBL] [Abstract][Full Text] [Related]
13. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.
Khan N; Afaq F; Khusro FH; Mustafa Adhami V; Suh Y; Mukhtar H
Int J Cancer; 2012 Apr; 130(7):1695-705. PubMed ID: 21618507
[TBL] [Abstract][Full Text] [Related]
14. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator.
Shuda M; Kwun HJ; Feng H; Chang Y; Moore PS
J Clin Invest; 2011 Sep; 121(9):3623-34. PubMed ID: 21841310
[TBL] [Abstract][Full Text] [Related]
15. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
[TBL] [Abstract][Full Text] [Related]
16. S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer.
Nawroth R; Stellwagen F; Schulz WA; Stoehr R; Hartmann A; Krause BJ; Gschwend JE; Retz M
PLoS One; 2011; 6(11):e27509. PubMed ID: 22110663
[TBL] [Abstract][Full Text] [Related]
17. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
Xu G; Zhang W; Bertram P; Zheng XF; McLeod H
Int J Oncol; 2004 Apr; 24(4):893-900. PubMed ID: 15010827
[TBL] [Abstract][Full Text] [Related]
19. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
[TBL] [Abstract][Full Text] [Related]
20. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
